Log in

CRNA Circio Holding ASA OSL · Norway

Circio Holding ASA (CRNA) news

Circio Holding ASA is a public biotech or pharmaceutical company listed on OSL under the ticker CRNA, recorded under Norway. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Circio Holding ASA news

We have not published a story on Circio Holding ASA yet. When there is news, it will appear here.

Questions about Circio Holding ASA

What is the ticker symbol of Circio Holding ASA?

Circio Holding ASA trades under the ticker CRNA on OSL.

Where is Circio Holding ASA listed?

Circio Holding ASA is listed on OSL. Our directory also records these other listings: GETTEX:TA50; LSE:0RIS; OMXSTO:CRNAO.

Which country or territory is Circio Holding ASA listed under?

Our directory records Circio Holding ASA under Norway.

What does Circio Holding ASA do?

Our directory classifies Circio Holding ASA as: Biotechnology. This is a directory classification, not a description of the pipeline.

What is the ISIN of Circio Holding ASA?

The ISIN recorded for Circio Holding ASA is NO0013033795.

Does aibio.space cover Circio Holding ASA?

aibio.space lists Circio Holding ASA among 2,820 public biotech companies and publishes its news here as stories appear.

Which companies are similar to Circio Holding ASA?

Companies in our directory listed in the same country and business area as Circio Holding ASA: Zelluna ASA, Arctic Bioscience AS, Nykode Therapeutics ASA, Oncoinvent ASA, Vistin Pharma ASA, Lytix Biopharma ASA.

Investor discussion: Circio Holding ASA

Members talk about Circio Holding ASA (CRNA). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open OSL:CRNA on TradingView.

Listing details

Circio Holding ASA is a public biotech or pharmaceutical company listed on OSL under the ticker CRNA, recorded under Norway. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
Circio Holding ASA
Ticker
CRNA
Listing
OSL
Country or territory
Norway
Business scope
Biotechnology
ISIN
NO0013033795
Other listed symbols
GETTEX:TA50; LSE:0RIS; OMXSTO:CRNAO
Last quote in directory
2026-10-22
Directory source
Listing page

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.